Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc/ US74112D1019 /
PBH
03.05.2024 22:10:00
|
Zm.
-1,26
|
Wolumen |
Bid02:00:00 |
Ask02:00:00 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
70,00USD
|
-1,77%
|
223 436 Obrót: 9,55 mln |
68,08Wolumen Bid: 100 |
72,07Wolumen Ask: 100 |
3,48 mldUSD |
- |
- |
Opis działalności
Prestige Consumer Healthcare, Inc. markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® and The Doctor's® oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® sore throat treatments, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia.
Zarząd & Rada nadzorcza
CEO |
Ron Lombardi |
Zarząd |
Christine Sacco, Adel Mekhail, Jeff Thompson, Jeff Zerillo, Mary Beth Fritz, William P'Pool |
Rada nadzorcza |
Ron Lombardi, Christopher J. Coughlin, Dawn M. Zier, Dr. Celeste A. Clark, Dr. Gary E. Costley, James M. Jenness, John E. Byom, Natale S. Ricciardi, Sheila A. Hopkins |
Dane firmy
Nazwa: |
Prestige Consumer Healthcare, Inc. |
Adres: |
660 White Plains Road,Tarrytown, New York 10591, USA |
Telefon: |
+1-914-524-6800 |
Fax: |
- |
E-mail: |
Irinquiries@prestigebrands.com
|
Internet: |
www.prestigebrandsinc.com/ |
Przemysł: |
Dobra konsumpcyjne |
Sektor: |
Kosmetyki |
Podsektor: |
Kosmetyki |
Koniec roku finansowego: |
31.03 |
Free float: |
69,88% |
Data IPO: |
- |
Relacje inwestorskie
Nazwa: |
Phil Terpolilli |
Telefon: |
+1-914-524-6819 |
Fax: |
- |
E-mail: |
-
|
Główni akcjonariusze
Freefloat |
|
69,88% |
BlackRock, Inc. |
|
12,50% |
The Vanguard Group |
|
10,72% |
Dimensional Fund Advisors LP |
|
6,90% |